Speakers
In his first entrepreneurial project, Paul was part of the founding team and raised seed capital for Homestead Capital, a private markets fund business based in San Francisco, California and focused on innovation in the agriculture sector. Homestead has grown to become a scaled leader in ownership and operation of institutional-quality farmland across the United States. Following the initial success of Homestead Capital, Paul created PacificBridge Capital to hold his Homestead Capital interest and to develop other startups within difficult-to-access world-changing themes. Examples of startups co-founded by Paul through PacificBridge Capital include: Brogent International, a genomics and bioinformatics company implementing precision medicine in Asia; ZiliNet, an AI-focused blockchain platform aiming to serve senior citizens in China; and Quiet Revolution, a neuroscience and psychology-focused business that provided personal development programs for corporations and schools (which Paul co-founded with New York Times best-selling author Susan Cain). Paul previously held leadership positions with JPMorgan for 15 years. For a decade, Paul served on the Global Management Team of JPMorgan Asset Management and/or The JPMorgan Private Bank. He served (sequentially) as CEO of The JPMorgan Private Bank in Asia; the US Premium (high net worth) segment of The JPMorgan Private Bank in the United States; and JPMorgan Invest, JPMorgan's business dedicated to retirement planning and investment in the United States. Prior to Paul’s chief executive roles, he served in leadership positions for JPMorgan Asset Management as an attorney, risk officer and Global Chief Fiduciary Officer. He joined JPMorgan in 1997 in Tokyo, where he served as Head of Legal and Compliance for JPMorgan’s Asia Investment Management and Private Banking business; relocated to London, where he served as Head of Legal and Compliance for JPMorgan’s Europe Investment Management and Private Banking business; and then moved to New York, where he was Head of Legal for JPMorgan’s Asset Management business in the Americas. Prior to joining JPMorgan, Paul was an Associate at Cleary Gottlieb Steen & Hamilton in New York and Tokyo, a leading global law firm. Paul earned his BS in Economics from James Madison University and his JD from the University of Pittsburgh School of Law. He clerked for the Honorable Conrad K. Cyr of the United States Court of Appeals for the First Circuit.
Cohen’s current research focus is on the emerging science of mitochondria-derived peptides, which he discovered. These peptides include humanin, a 24-amino acid peptide encoded from the mt-16S-rRNA. It is a novel, centrally acting insulin sensitizer and metaboloprotective factor representing a new therapeutic and diagnostic target in diabetes and related disease. Other mitochondrial peptides of interest include MOTS-c, a second peptide encoded from a small ORF in the 12S region of the mitochondrial chromosome that has potent anti-diabetes and anti-obesity effect and acts as an exercise-mimetic, and SHLP2, a peptide encoded from the light strand of the mt-16S-rRNA region whose levels correlate with prostate cancer.
He has received numerous awards for his research, including a National Institute of Aging “EUREKA” Award and the National Institutes of Health Director Transformative RO1 Grant. He also recently received the American Federation of Aging Research Irving S. Wright Award of Distinction and the Glenn Award for Research in Biological Mechanisms of Aging. Cohen is a past president of the Growth Hormone Society and has served on the Endocrine Society Steering Committee. He sits on multiple NIH study sections and on several editorial boards as well as on the American Federation of Aging Research Board. He also holds several patents for novel peptides and is the cofounder of CohBar, a biotechnology company developing mitochondrial peptides for diabetes.
As dean, Cohen is leading several new initiatives at the USC Leonard Davis School, including a major focus on the creation of tools for “personalized aging,” an approach using technologies such as genomics towards individualizing healthy aging strategies, which has been featured in the Milken Global Conference and in the Bloomberg Longevity Economy Conference. He also leads the Ensuring Lifespan Health initiative at USC.
Prior to his arrival at USC in 2012, he was a professor and vice chair for research at the Mattel Children’s Hospital at UCLA as well as the co-director of the UCSD/UCLA Diabetes Research Center. He completed his postdoctoral training at Stanford and held his first faculty position at the University of Pennsylvania from 1992 to 1999. He earned an MD in 1986 at the Technion in Haifa, Israel.
Corbin danced professionally for The Washington Ballet, Kansas City Ballet and ABT II between 1981 and 1985. After dancing with the Joffrey Ballet for four years, Corbin joined the Paul Taylor Dance Company in 1989 and became one of the company’s most celebrated artists until his departure in 2005. Corbin has been featured in five PBS Great Performances between 1988 and 2004, as well as in the 1998 Academy Award-nominated documentary, Dancemaker. In 2001, Corbin was the recipient of the New York Performance Award (Bessie) for Sustained Achievement with The Paul Taylor Dance Company. Corbin founded his own company CorbinDances in 2003, and stages his own work as well as the work of Paul Taylor on companies throughout the United States.
In addition to his career as a dancer, Corbin has been a guest faculty member at the Conservatoire National Supérieur de Musique et de Danse de Paris, University of California Irvine, George Mason University, SUNY Purchase, University of Kansas, University of Texas Austin and University of Michigan and has taught professionally for American Ballet Theater, Miami City Ballet and San Francisco Ballet.
Under his leadership, Marshall has launched NEW INTERDISCIPLINARY JOINT UNDERGRADUATE DEGREES with other USC schools, STEM-CERTIFIED all undergraduate programs, and grown Marshall's graduate BUSINESS ANALYTICS and FINANCE programs. During his first years as dean, the undergraduate business program reached GENDER PARITY for its incoming classes and Marshall launched a FACULTY HIRING INITIATIVE focused on analytics, finance, and leadership while increasing diversity amongst faculty.
Garrett previously taught at USC from 2005-2008 as a professor of international relations, business administration, communications, and law while also serving as President of the Pacific Council on International Policy. In his native Australia, Garrett was the founding CEO of the United States Studies Centre and dean of the business schools at both The University of Sydney (USYD) and The University of New South Wales (UNSW). A distinguished international political economist, Garrett has also held academic appointments at Oxford, Stanford, and Yale universities and is a member of the Australian Academy of the Social Sciences.
Garrett is widely recognized as a leading global business expert and has been featured in numerous media outlets, including The New York Times, The Wall Street Journal, The Financial Times, and The Economist. He has authored books on globalization, politics, and the global diffusion of democracy and markets.
He also serves on the board of directors for Park Hotels and Resorts, the Governing Council of the BITS School of Management in India, and the International Advisory Board of Zhejiang University International Business School (ZIBS) in China. He is a winner of the Foreign Police Association Medal and the Advance Global Australian Award.
Garrett holds a BA (Honors) from the Australian National University, and an MA and PhD from Duke University, where he was a Fulbright Scholar.
David’s prior career experience spanned both startup and public companies, including Apple, QUALCOMM, Four11 (now Yahoo! Mail), and two computer security software developers.
David is also on the board of Metro-Goldwyn-Mayer Inc. (MGM), a member of Young President’s Organization (YPO), and a long-time advisor to the Stanford Graduate School of Business. David received his Bachelor of Arts in journalism from Indiana University Bloomington. As a proud Hoosier alumnus, he has served on the Dean’s advisory board for the IU School of Informatics, Computing, and Engineering. David resides in the Bay Area with his wife, three children, and their two labradoodles.
Prior to Stanley X, she helped lead Technology Innovation and Entrepreneurship at USC's Viterbi School of Engineering. Under her leadership the school launched its first deep technology incubator, the Viterbi Startup Garage, where she created an ecosystem for venture acceleration and training to rapidly launch technology companies. She was named an Amazon Alexa Innovation Fellow in 2018. Prior to this, Alice was Director of Business Development and Strategy at Applied Minds, a multidisciplinary innovation company that designs, builds, and creates new technology solutions and companies in partnership with leading corporations and entrepreneurs. She started her career in management strategy consulting at Bain and Company and Boston Consulting Group.
Alice holds a B.S. in Biology and Ph.D. in Computational Neural Systems from Caltech, where she also taught data science and machine learning, and served on the Board of Directors of the Caltech Y and the Caltech Alumni Association.
In addition to his clinical work, Dr. Mutter is active in undergraduate and graduate medical education, serving as the Director of Health Humanities Programs for the UVA Center for Health Humanities and Ethics. He holds an MSc in the History of Science, Medicine, and Technology from the University of Oxford, where he was a Rhodes Scholar. Among other grants, he is past grantee of the Geriatric Academic Career Award from the Health Resources and Services Administration, focusing on interprofessional geriatric education in medicine, nursing, and pharmacy. He is a prior fellow of the Institute for Advanced Studies in Culture at UVA, and core faculty for UVA’s Generalist Scholars Program. In addition to providing training in geriatrics and medical humanities in the UVA School of Medicine, Dr. Mutter teaches courses on aging and society in the UVA College of Arts and Sciences. His scholarship and research interests include studies in the historical political economy of aging in the United States, the history of regulatory medicine, and primary care health policy.
In his first entrepreneurial project, Paul was part of the founding team and raised seed capital for Homestead Capital, a private markets fund business based in San Francisco, California and focused on innovation in the agriculture sector. Homestead has grown to become a scaled leader in ownership and operation of institutional-quality farmland across the United States. Following the initial success of Homestead Capital, Paul created PacificBridge Capital to hold his Homestead Capital interest and to develop other startups within difficult-to-access world-changing themes. Examples of startups co-founded by Paul through PacificBridge Capital include: Brogent International, a genomics and bioinformatics company implementing precision medicine in Asia; ZiliNet, an AI-focused blockchain platform aiming to serve senior citizens in China; and Quiet Revolution, a neuroscience and psychology-focused business that provided personal development programs for corporations and schools (which Paul co-founded with New York Times best-selling author Susan Cain). Paul previously held leadership positions with JPMorgan for 15 years. For a decade, Paul served on the Global Management Team of JPMorgan Asset Management and/or The JPMorgan Private Bank. He served (sequentially) as CEO of The JPMorgan Private Bank in Asia; the US Premium (high net worth) segment of The JPMorgan Private Bank in the United States; and JPMorgan Invest, JPMorgan's business dedicated to retirement planning and investment in the United States. Prior to Paul’s chief executive roles, he served in leadership positions for JPMorgan Asset Management as an attorney, risk officer and Global Chief Fiduciary Officer. He joined JPMorgan in 1997 in Tokyo, where he served as Head of Legal and Compliance for JPMorgan’s Asia Investment Management and Private Banking business; relocated to London, where he served as Head of Legal and Compliance for JPMorgan’s Europe Investment Management and Private Banking business; and then moved to New York, where he was Head of Legal for JPMorgan’s Asset Management business in the Americas. Prior to joining JPMorgan, Paul was an Associate at Cleary Gottlieb Steen & Hamilton in New York and Tokyo, a leading global law firm. Paul earned his BS in Economics from James Madison University and his JD from the University of Pittsburgh School of Law. He clerked for the Honorable Conrad K. Cyr of the United States Court of Appeals for the First Circuit.
Before launching Magnify, Julie spent over a decade as an investor and advisor with institutional scale family offices and mission-focused organizations, including launching and leading the venture capital investment portfolio and strategy at Pivotal Ventures, an investment and incubation company created by Melinda French Gates to advance social progress in the United States.
In her roles, Julie has invested in pre-revenue startups, category-defining companies, and industry-leading venture capital firms, and she’s built partnerships across sectors to seed innovation in emergent markets. Julie is a Kauffman Fellow and member of All Raise.